Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SELLAS Life Sciences Group, Inc. Director's Dealing 2016

Nov 16, 2016

33651_dirs_2016-11-15_27e62d22-39c6-4006-b7d3-7905c20f46c7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2016-11-01

Reporting Person: Ghiglieri Stephen F (Chief Financial Officer)